4 results found.

Pre-eclampsia, or Intra-uterine Growth Retardation Clinical Trial using blood sample and doppler Ultrasound of uterine arteries

Institut National de la Sant‚ Et de la Recherche M‚dicale, France - Recruiting 18 years or older.
- EG-VEGF (Endocrine Gland-derived Vascular Endothelial Growth Factor) in Normal and Pathological Pregnancies: Potential Marker of Pre-eclampsia and / or Intrauterine Growth Restriction.
blood sample and doppler Ultrasound of uterine arteries

Small for Gestational Age (Disorder), or Pre-Eclampsia Clinical Trial

Assaf-Harofeh Medical Center - Recruiting 18 years to 50 years.
- Establishing First Trimester Sonographic, Biochemical and Clinical Markers for the Identification of High Risk Twin in the First Trimester.

Pre-eclampsia Clinical Trial using Placebo; RLX030

Novartis - Recruiting 18 years to 40 years.
- An Adaptive Multicentre, Randomized, Partially Double-blind, Placebo-controlled Study to Assess the Safety, PK and PD/Efficacy of RLX030 in Women With Pre-eclampsia.
Placebo; RLX030

Pre-eclampsia Clinical Trial

Cukurova University - Recruiting 16 years to 50 years.
- Random Urine Protein-creatinine Ratio to Predict Magnitude of Proteinuria in Different Severity of Pre-eclamptic Patients.